Live respiratory syncytial virus (RSV) vaccine candidate containing stabilized temperature-sensitivity mutations is highly attenuated in RSV-seronegative infants and children

Ursula J. Buchholz*, Coleen K. Cunningham, Petronella Muresan, Devasena Gnanashanmugam, Paul Sato, George K. Siberry, Vivian Rexroad, Megan Valentine, Charlotte Perlowski, Elizabeth Schappell, Bhagvinji Thumar, Cindy Luongo, Emily Barr, Mariam Aziz, Ram Yogev, Stephen A. Spector, Peter L. Collins, Elizabeth J. McFarland, Ruth A. Karron

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Live respiratory syncytial virus (RSV) vaccine candidate containing stabilized temperature-sensitivity mutations is highly attenuated in RSV-seronegative infants and children'. Together they form a unique fingerprint.

INIS

Biochemistry, Genetics and Molecular Biology